Salus Scientific Corp. files Form D for securities offering

Salus Scientific Corp. has recently filed a Form D, which indicates that the company is engaging in an exempt offering of securities. This move is significant as it suggests that Salus is looking to raise capital, potentially for expansion or operational needs.

Salus Scientific Corp. is based in Charleston, South Carolina. The company is categorized under the SIC description for other entities, reflecting its diverse operations in the scientific research sector. The firm has been active in filing with the SEC, with its most recent filings including a Form D on October 22, 2026, and prior filings in August and February of the same year.

The filing states, "Effectiveness Date: 2026-10-22," indicating that the offering is now active. This is an important step for the company as it seeks to attract investors and secure funding.

This development may affect current and prospective investors, as well as stakeholders in the scientific research field. The capital raised through this offering could be used to enhance Salus Scientific's capabilities and market position.

Details were not available in the SEC filing regarding the specific use of funds or the terms of the offering. The filing does not say what happens next.

In the filing, Salus Scientific Corp. has provided its mailing and business address, which is located at 475 Jessen Lane, Suite 500, Charleston, SC 29492. This location may serve as a central hub for the company’s operations and investor relations.

The company is identified by its Central Index Key (CIK) number 0001952070, and it has an Employer Identification Number (EIN) of 851543518. This information is crucial for regulatory purposes and for investors seeking to verify the company's identity and compliance.

Furthermore, the filing indicates that Salus Scientific Corp. is incorporated in South Carolina and has a fiscal year that ends on December 31. This detail may provide insights into the company’s financial reporting schedule and tax obligations.

While the filing confirms the acceptance and effectiveness date of the offering, it does not specify the total amount of securities being offered or the specific types of investors being targeted. Additionally, there are no details regarding the anticipated timeline for the capital raise or potential follow-up filings that may occur as the offering progresses.